Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 601–700 of 1,004
Sparsø, T., Grarup, N., Andreasen, C. H., Albrechtsen, A., Holmkvist, J., Andersen, G., Jørgensen, T., Borch‐Johnsen, K., Sandbæk, A., Lauritzen, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1362-3 · Cited by 66
“Until recently, only three gene loci, PPARG [1], KCNJ11 [2, 3] and TCF7L2 [4], had convincingly shown replicated association with type 2 diabetes.”
BackgroundGenetic Susceptibility to Type 2 Diabetes and Implications for Antidiabetic Therapy
Moore, A. F., & Florez, J. C. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.090706.135315 · Cited by 66
Discovery and assessment of conserved Pax6 target genes and enhancers
Coutinho, P., Pavlou, S., Bhatia, S., Chalmers, K. J., Kleinjan, D. A., & van Heyningen, V. (2011) · Genome Research · doi:10.1101/gr.124115.111 · Cited by 59
Fujita, Y., Chui, J. W. Y., King, D. S., Zhang, T., Seufert, J., Pownall, S., Cheung, A. T., & Kieffer, T. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90440.2008 · Cited by 59
“TCF4 may couple Wnt signaling to increased proglucagon transcription (41), and interestingly recent studies (15, 16) suggest that polymorphisms in the TCF7L2 ( TCF4) gene constitute a major risk factor for diabetes.”
BackgroundConsiderations Regarding the Genetics of Obesity
Chung, W. K., & Leibel, R. L. (2008) · Obesity · doi:10.1038/oby.2008.514 · Cited by 72
Alkelai, A., Greenbaum, L., Lupoli, S., Kohn, Y., Kanyas, K., Ben‐Asher, E., Lancet, D., Macciardi, F. M., & Lerer, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029228 · Cited by 62
“Following the first report of Grant and colleagues [41] of association of TCF7L2 gene variants with T2D, a large number of studies in various populations have replicated the original findings [42,43,44,45,46,47,48,49,50,51,52,53].”
BackgroundIp, W., Shao, W., Song, Z., Chen, Z., Wheeler, M. B., & Jin, T. (2015) · Diabetes · doi:10.2337/db14-1329 · Cited by 61
“Initial studies were primarily conducted in pancreas or pancreatic b-cells as impaired GLP-1–induced insulin secretion was observed in TCF7L2 T2D risk single nucleotide polymorphism carriers (3).”
BackgroundInfluentialPathogenesis of Type 2 Diabetes
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2007) · Endocrine Research · doi:10.1080/07435800701743810 · Cited by 56
“GLP-1 is one of the peptides encoded by this gene; it has stimulating effects both on insulin secretion per se, and on beta-cell growth (89).”
BackgroundExamination of All Type 2 Diabetes GWAS Loci Reveals HHEX-IDE as a Locus Influencing Pediatric BMI
Zhao, J., Bradfield, J. P., Zhang, H., Annaiah, K., Wang, K., Kim, C., Glessner, J., Frackelton, E. C., Otieno, F. G., Doran, J., et al. (2009) · Diabetes · doi:10.2337/db09-0972 · Cited by 62
“The strongest association in European populations has been with a gene established in 2006, namely, the Wnt-signaling pathway member transcription factor 7–like 2 (TCF7L2) (10), while in China and Japan, the strongest association has been with the gene encoding potassium channel, voltage-gated, KQT-like subfamily, mem…”
BackgroundSelf-citationObesity, adipogenesis and insulin resistance
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.004 · Cited by 68
Consistently Replicating Locus Linked to Migraine on 10q22-q23
Anttila, V., Nyholt, D. R., Kallela, M., Artto, V., Vepsäläinen, S., Jakkula, E., Wennerström, A., Tikka-Kleemola, P., Kaunisto, M. A., Hämäläinen, E., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.03.003 · Cited by 66
An approach for cutting large and complex pedigrees for linkage analysis
Liu, F., Kirichenko, A. V., Axenovich, T. I., van Duijn, C. M., & Aulchenko, Y. S. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.24 · Cited by 57
The role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 65
DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
Raciti, G. A., Desiderio, A., Longo, M., Leone, A., Zatterale, F., Prevenzano, I., Miele, C., Napoli, R., & Bèguinot, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111652 · Cited by 66
Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)
Zampetti, S., Spoletini, M., Petrone, A., Capizzi, M., Arpi, M. L., Tiberti, C., Di Pietro, S., Bosi, E., Pozzilli, P., Giorgino, F., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02997.x · Cited by 54
Benzler, J., Andrews, Z. B., Pracht, C., Stöhr, S., Shepherd, P. R., Grattan, D. R., & Tups, A. (2013) · Endocrinology · doi:10.1210/en.2013-1746 · Cited by 60
Bagarolli, R. A., Saad, M. J. A., & Saad, S. T. O. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.03.003 · Cited by 59
Genetics of Type 2 Diabetes in East Asian Populations
Cho, Y. S., Lee, J., Park, K. S., & Nho, C. W. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0326-z · Cited by 60
“Another study from the European Prospective Investigation into Cancer and Nutrition (EPIC)–Postdam cohort suggested that the protective effect of whole grains on T2D risk might be reduced in the presence of the risk allele of TCF7L2 rs7903146 [85].”
BackgroundInfluentialBressler, J., Folsom, A. R., Couper, D. J., Volcik, K. A., & Boerwinkle, E. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp377 · Cited by 54
Rajamani, U., Gross, A. R., Hjelm, B. E., Sequeira, A., Vawter, M. P., Tang, J., Gangalapudi, V., Wang, Y., Andres, A. M., Gottlieb, R. A., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.009 · Cited by 56
“We found that TCF7L2 is lower in OBS individuals thereby possibly causing an increase in the production of proglucagon and risk of developing diabetes (Grant et al., 2006).”
DNA methylation landscapes in the pathogenesis of type 2 diabetes mellitus
Zhou, Z. G., Sun, B., Li, X., & Zhu, C. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0283-x · Cited by 70
Genetic Studies of Gestational Diabetes and Glucose Metabolism in Pregnancy
Powe, C. E., & Kwak, S. H. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01355-3 · Cited by 52
Burwinkel, B., Shanmugam, K. S., Hemminki, K., Meindl, A., Schmutzler, R. K., Sutter, C., Wappenschmidt, B., Kiechle, M. B., Bartram, C. R., & Frank, B. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-268 · Cited by 55
“Results and discussion The TCF7L2 rs12255372 T allele frequency of the controls (German Caucasians) was in accordance with those published in previous studies (Danish, Dutch, Icelandic and US Caucasians) [2-4], and the frequencies of rs12255372 genotypes were consistent with Hardy-Weinberg equilibrium (P = 0.”
BackgroundResultInfluentialMechanisms of Disease: genetic insights into the etiology of type 2 diabetes and obesity
Lindgren, C. M., & McCarthy, M. I. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0723 · Cited by 64
“The first clues that this 'hypothesis-free' approach to gene identification would succeed came from the discovery that variants within TCF7L2 (transcription factor 7-like 2 gene) influenced susceptibility to T2D in Icelandic individuals”
BackgroundLatent autoimmune diabetes in adults (LADA)—more than a name
Groop, L., Tuomilehto, J., Rowley, M., Zimmet, P., & Mackay, I. R. (2006) · Diabetologia · doi:10.1007/s00125-006-0345-x · Cited by 64
“the Pro12Ala single-nucleotide polymorphism in PPARG, the E23K SNP in KCNJ11, or the recently described polymorphisms in TCF7L2 [13–15].”
BackgroundThe association of genetic variants of type 2 diabetes with kidney function
Franceschini, N., Shara, N. M., Wang, H., Voruganti, V. S., Laston, S., Haack, K., Lee, E. T., Best, L. G., MacCluer, J. W., Cochran, B. J., et al. (2012) · Kidney International · doi:10.1038/ki.2012.107 · Cited by 57
Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner
Sakhneny, L., Rachi, E., Epshtein, A., Guez, H., Wald-Altman, S., Lisnyansky, M., Khalifa-Malka, L., Hazan, A. T., Baer, D., Priel, A., et al. (2017) · Diabetes · doi:10.2337/db17-0697 · Cited by 56
Progress in Metabonomics of Type 2 Diabetes Mellitus
Ma, Q., Li, Y., Wang, M., Tang, Z., Wang, T., Liu, C., Wang, C., & Zhao, B. (2018) · Molecules · doi:10.3390/molecules23071834 · Cited by 58
“GLP-1 has stimulating effects both on insulin secretion and on β-cell growth [13].”
BackgroundAly, R. H., Ahmed, A. E., Hozayen, W. G., Rabea, A. M., Ali, T. M., Askary, A. E., & Ahmed, O. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.609223 · Cited by 54
Lettre, G., Butler, J. L., Ardlie, K., & Hirschhorn, J. N. (2007) · Human Genetics · doi:10.1007/s00439-007-0385-4 · Cited by 58
“…in complex trait genetics suggest that many complex human diseases will be explained in part by genetic variants in novel and often unexpected genes (Amundadottir et al. 2006; Edwards et al. 2005; Freedman et al. 2006; Grant et al. 2006; Haines et al. 2005; Klein et al. 2005; Sladek et al. 2007).”
BackgroundMeta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population
Luo, Y., Wang, H., Han, X., Ren, Q., Wang, F., Zhang, X., Sun, X., Zhou, X., & Ji, L. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.024 · Cited by 61
Application of nutrigenomic concepts to Type 2 diabetes mellitus
Kaput, J., Noble, J. A., Hatipoğlu, B., Kari Kohrs, E., Dawson, K., & Bartholomew, A. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.11.006 · Cited by 64
“TCF7L2 Transcription factor Blood glucose homeostasis T of rs7903146 & T of rs12255372 [148]”
BackgroundRole and Regulation of Wnt/β-Catenin in Hepatic Perivenous Zonation and Physiological Homeostasis
Goel, C., Monga, S. P., & Nejak-Bowen, K. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.09.007 · Cited by 53
Regulatory variants in TCF7L2 are associated with thoracic aortic aneurysm
Roychowdhury, T., Lu, H., Hornsby, W., Crone, B., Wang, G. T., Guo, D., Sendamarai, A. K., Devineni, P., Lin, M., Zhou, W., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.06.016 · Cited by 58
“Comparison of the TCF7L2 association with TAA and type 2 diabetes TCF7L2 is known to be associated with T2D.(41) A common variant in the 3 intron of TCF7L2 is associated with T2D and most likely causes a defect in insulin secretion in the pancreas.”
BackgroundInfluentialThe broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes
del Bosque‐Plata, L., Hernández‐Cortés, E. P., & Gragnoli, C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30581 · Cited by 63
Wong, A. M., Ding, X., Wong, A. M. G., Xu, M., Zhang, L., Leung, H. H. W., Chan, A. W. H., Song, Q. X., Kwong, J., Chan, L. K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.015 · Cited by 64
Glucagon and Glucagon-Like Peptides 1 and 2
Holst, J. J. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_35 · Cited by 56
“These findings raise the possibility that this SNP influences disease susceptibility through modulation of intestinal progucagon gene expression and hence possibly plasma levels of GLP-1 (Grant et al. 2006).”
BackgroundRegulation of Pancreatic Juxtaductal Endocrine Cell Formation by FoxO1
Kitamura, T., Kitamura, Y., Kobayashi, M., Kikuchi, O., Sasaki, T., DePinho, R. A., & Accili, D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01622-08 · Cited by 53
“Moreover, given that most of the newly found diabetes susceptibility genes appear to affect -cell function rather than insulin action (12, 41, 43), that the two newest classes of antidiabetic medications are -tropic (2), and that the main therapeutic failures in diabetes are seen in response to -tropic agents (19, 48)…”
BackgroundInsights into the genetic basis of type 2 diabetes
Kato, N. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12067 · Cited by 65
Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway
Zhou, Y., Zhang, E., Berggreen, C., Jing, X., Osmark, P., Lang, S., Cilio, C., Göransson, O., Groop, L., Renström, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr454 · Cited by 59
“TCF7L2 (2), ADAMTS9 and TP53INP1 (16).”
BackgroundAl-Rubeaan, K. A., Siddiqui, K., Saeb, A. T. M., Nazir, N., Alnaqeb, D., & Al-Qasim, S. (2013) · Gene · doi:10.1016/j.gene.2013.02.017 · Cited by 57
Qi, Q., Li, H., Loos, R. J. F., Liu, C., Wu, Y., Hu, F. B., Wu, H., Lu, L., Yu, Z., & Xu, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp294 · Cited by 53
Maeda, S., Osawa, N., Hayashi, T., Tsukada, S., Kobayashi, M., & Kikkawa, R. (2007) · Kidney International · doi:10.1038/sj.ki.5002385 · Cited by 57
Predictive genetic testing for type 2 diabetes
Janssens, A. C. J. W., GWINN, M. L., Valdez, R. A., Narayan, K. M. V., & Khoury, M. J. (2006) · BMJ · doi:10.1136/bmj.38953.598947.80 · Cited by 53
The genetics of type 2 diabetes and its clinical relevance
Pal, A., & McCarthy, M. (2013) · Clinical Genetics · doi:10.1111/cge.12055 · Cited by 52
“The first round of GWAS in 2007 confirmed known loci at PPARG , KCNJ11 and near TCF7L2 (first identified ahead of the GWAS era by detailed association analysis of a previously demonstrated linkage signal on chromosome 10q (9)), in addition to revealing novel loci including signals near CDKAL1 , HHEX , SLC30A8 , IGF2BP…”
BackgroundAssociation of TCF7L2 polymorphisms with type 2 diabetes in Mexico City
Parra, E. J., Cameron, E., Simmonds, L., Valladares, A., McKeigue, P., Shriver, M. D., Wacher, N. H., Kumate, J., Kittles, R. A., & Cruz, M. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00780.x · Cited by 58
“(1) reported the association between the microsatellite DG10S478 located within intron 3 of the transcription factor 7-like 2 gene (TCF7L2) with type 2 diabetes (T2D) in Icelandic individuals.”
BackgroundResultInfluentialTCF7L2 promotes beta cell regeneration in human and mouse pancreas
Shu, L., Zien, K. S., Gutjahr, G., Oberholzer, J., Pattou, F. N., Kerr-Conte, J. A., & Maedler, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2693-z · Cited by 56
“Worldwide studies have reported a strong linkage of single nucleotide polymorphisms in the TCF7L2 gene with type 2 diabetes [1].”
BackgroundImportance of β-Catenin in glucose and energy homeostasis
Elghazi, L., Gould, A. P., Weiss, A. J., Barker, D. J., Callaghan, J., Opland, D. M., Myers, M. G., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2012) · Scientific Reports · doi:10.1038/srep00693 · Cited by 62
New Strategies for Alzheimer Disease and Cognitive Impairment
Maiese, K., Chong, Z. Z., Hou, J., & Shang, Y. C. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9990 · Cited by 52
Consistent Directions of Effect for Established Type 2 Diabetes Risk Variants Across Populations
Haiman, C. A., Fesinmeyer, M. D., Spencer, K. L., Bůžková, P., Voruganti, V. S., Wan, P. C., Haessler, J., Franceschini, N., Monroe, K. R., Howard, B. V., et al. (2012) · Diabetes · doi:10.2337/db11-1296 · Cited by 58
Granhall, C., Park, H.-B., Fakhrai-Rad, H., & Luthman, H. (2006) · Genetics · doi:10.1534/genetics.106.062208 · Cited by 60
Kang, E. S., Kim, M. S., Kim, Y. S., Hur, K. Y., Han, S. J., Nam, C. M., Ahn, C. W., Soo, B., Kim, S. I., & Lee, H. C. (2007) · Diabetes Care · doi:10.2337/dc07-1005 · Cited by 52
Dahlgren, A., Zethelius, B., Jensevik, K., Syvänen, A.-C., & Berne, C. (2007) · Diabetologia · doi:10.1007/s00125-007-0746-5 · Cited by 58
“The search for genetic variants underlying type 2 diabetes mellitus has had limited success in the past [1, 2], until recently when Grant and colleagues showed a significant association between a microsatellite marker (DG10S478) located in the transcription factor 7-like 2 gene (TCF7L2) and the risk of type 2 diabetes…”
BackgroundResultInfluentialTAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
Hwang, J.-H., Kim, A. R., Kim, K. M., Park, J. I., Oh, H. T., Moon, S. A., Byun, M. R., Jeong, H., Kim, H. K., Yaffe, M. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08287-x · Cited by 59
Zheng, N. S., Feng, Q., Kerchberger, V. E., Zhao, J., Edwards, T. L., Cox, N. J., Stein, C. M., Roden, D. M., Denny, J. C., & Wei, W. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa104 · Cited by 56
“For T2DM, both PheMap and eMERGE replicated association signals in the TCF7L2 and FTO loci at the genome-wide significance level of P < 5 10 (8).(36,38) PheMap also identified an association signal for HLA and COBLL1, while eMERGE identified an association signal for IGF2BP2.”
ResultA strategy to search for common obesity and type 2 diabetes genes
Elbers, C. C., Onland‐Moret, N. C., Franke, L., Niehoff, A. G., van der Schouw, Y. T., & Wijmenga, C. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.11.003 · Cited by 51
Bielinski, S. J., Pankow, J. S., Folsom, A. R., North, K. E., & Boerwinkle, E. (2008) · Diabetologia · doi:10.1007/s00125-008-1004-1 · Cited by 53
“Polymorphisms of TCF7L2 have been associated with diabetes in numerous studies [1–3] and the magnitude of risk conferred by TCF7L2 variants is greater than for any previously described common variant.”
BackgroundTCF7L2 Variants Associate with CKD Progression and Renal Function in Population-Based Cohorts
Köttgen, A., Hwang, S., Rampersaud, E., Coresh, J., North, K. E., Pankow, J. S., Meigs, J. B., Florez, J. C., Parsa, A., Levy, D. A., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121291 · Cited by 52
Polyunsaturated Fatty Acids Modulate the Effect of TCF7L2 Gene Variants on Postprandial Lipemia
Warodomwichit, D., Arnett, D. K., Kabagambe, E. K., Tsai, M. Y., Hixson, J. E., Straka, R. J., Province, M. A., An, P., Lai, C., Borecki, I. B., et al. (2009) · Journal of Nutrition · doi:10.3945/jn.108.096461 · Cited by 51
“More specifically, a microsatellite marker DG10S478 within intron 3 of TCF7L2 was associated with diabetes in 3 independent case-control studies, mainly in Caucasians (4).”
BackgroundPast, present and future of latent autoimmune diabetes in adults
Liu, B., Xiang, Y., Liu, Z., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3205 · Cited by 50
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
Harini, K. S., & Ezhilarasan, D. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.10.003 · Cited by 57
Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
McKillop, A. M., & Flatt, P. R. (2011) · Diabetes Care · doi:10.2337/dc11-0837 · Cited by 57
“Indeed, the most important finding using linkage studies is the discovery that the alteration of TCF7L2 (TCF-4) gene expression or function (33) disrupts pancreatic islet function and results in enhanced risk of type 2 diabetes.”
BackgroundObesidad, adipogénesis y resistencia a la insulina
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.05.008 · Cited by 92
Sorrenson, B., Cognard, E., Lee, K. L., Dissanayake, W. C., Fu, Y., Han, W., Hughes, W. E., & Shepherd, P. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.758516 · Cited by 54
“siRNA specific to β-catenin, the effect of GLP-1 [7-36] amide on GSIS was reduced in a manner that was comparable to that observed for exenatide (Fig.”
BackgroundMethodResultInfluentialPolonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 77
Contreras, O., Soliman, H. S., Théret, M., Rossi, F. M. V., & Brandan, E. (2020) · Journal of Cell Science · doi:10.1242/jcs.242297 · Cited by 54
Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Cummings, J., Ortiz, A., Castellino, J., & Kinney, J. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15619 · Cited by 48
Topol, E. J., & Frazer, K. A. (2007) · Nature Genetics · doi:10.1038/ng0407-439 · Cited by 51
Buonvino, S., Arciero, I., & Melino, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158452 · Cited by 54
“Obesity is related not only to an obesogenic environment, but also to a genetic susceptibility [125,126] and similarly DMT2 is linked to the combination of an unhealthy lifestyle (overnutrition and sedentary life) with the genotype of the subject [127,128].”
BackgroundGupta, V., Khadgawat, R., Ng, H. K. T., Kumar, S., Aggarwal, A., Rao, V. R., & SACHDEVA, M. P. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2010.00580.x · Cited by 49
“103 respectively for this particular population, confirming their general magnitude of risk (17%-28%) (Grant et al., 2006).”
BackgroundAlmasy, L. A., & Blangero, J. (2008) · Genetica · doi:10.1007/s10709-008-9305-3 · Cited by 60
“Another group found confirmatory linkage evidence in the same chromosomal region (Reynisdottir et al. 2003) and eventually identified the TCF7L2 gene under their linkage peak as being strongly associated with type 2 diabetes (Grant et al. 2006).”
BackgroundKong, X., Zhang, X., Xing, X., Zhang, B., Hong, J., & Yang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143607 · Cited by 55
“However, due to a relatively lower MAF of rs7903146 in Chinese Hans (0.029 reported by HapMap project) compared with Caucasians (0.308 reported by 1000 Genome project), larger sample sizes are required to achieve enough statistical power in Chinese.”
BackgroundInfluentialSrinivasan, S., Kaur, V., Chamarthi, B., Littleton, K. R., Chen, L., Manning, A. K., Merino, J., Thomas, M. K., Hudson, M., Goldfine, A. B., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1386 · Cited by 55
Fraszczyk, E., Luijten, M., Spijkerman, A. M. W., Snieder, H., Wackers, P. F. K., Bloks, V. W., Nicoletti, C. F., Nonino, C. B., Crujeiras, A. B., Buurman, W. A., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-019-0790-2 · Cited by 55
Hamsten, A., & Eriksson, P. O. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01958.x · Cited by 59
Gao, B., Huang, Q., Lin, Y., Wei, B.-Y., Guo, Y., Sun, Z., Wang, L., Fan, J., Zhang, H., Han, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099137 · Cited by 56
“Recent studies in humans have shown mutations in Wnt signaling molecules to result in different diseases [11,12,13].”
BackgroundTwins in metabolic and diabetes research: what do they tell us?
Vaag, A. A., & Poulsen, P. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282ab9ea6 · Cited by 49
Johansson, S., Ræder, H., Eide, S. Å., Midthjell, K., Hveem, K., Sövik, O., Molven, A., & Njølstad, P. R. (2007) · Diabetes · doi:10.2337/db07-0513 · Cited by 50
Genetic analysis implicates resistin in HIV lipodystrophy
Ranade, K., Geese, W. J., Noor, M. A., Flint, O. P., Tebas, P., Mulligan, K. M., Powderly, W. G., Grinspoon, S. K., & Dubé, M. P. (2008) · AIDS · doi:10.1097/qad.0b013e32830a9886 · Cited by 49
“Sequence comparison revealed that this SNP is located in a consensus binding site for the T-cell transcription factor, TCF7L2, which has been previously implicated in susceptibility to Type II diabetes [33].”
BackgroundLee, M., Yoon, J., Song, H., Lee, B., Lam, D. T., Yoon, J., Baek, K., Clevers, H., & Jeong, Y. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.02.010 · Cited by 48
Premature myocardial infarction is associated with low serum levels of Wnt-1
Goliasch, G., Wiesbauer, F., Kastl, S., Katsaros, K. M., Blessberger, H., Maurer, G., Schillinger, M., Huber, K., Wojta, J., & Speidl, W. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.017 · Cited by 56
The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells
Norton, L., Chen, X., Fourcaudot, M., Acharya, N. K., DeFronzo, R. A., & Heikkinen, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1225 · Cited by 47
“As a key member of the TCF family of transcription factors, TCF7L2 (transcription factor 7-like 2) is unique in that its gene is the most significant type 2 diabetes (T2DM) candidate gene identified to date (7), and recently attention has focused on the molecular and physiological role of TCF7L2 in the tissues relevan…”
BackgroundHypothalamic Wnt Signalling and its Role in Energy Balance Regulation
Helfer, G., & Tups, A. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12368 · Cited by 53
“An initial, striking link between Wnt signalling and metabolic impairments was established by genome-wide association studies in humans that linked the transcriptional co-activator of b -catenin, TCF7/L2, with a higher risk of developing type 2 diabetes (23–25).”
atherosclerosis: gone with the Wnt?
Boucher, P., Matz, R. L., & Terrand, J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.03.024 · Cited by 56
100 YEARS OF INSULIN: Towards improved precision and a new classification of diabetes mellitus
Ahlqvist, E., Prasad, R. B., & Groop, L. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0596 · Cited by 62
Identification of ALOX5 as a gene regulating adiposity and pancreatic function
Mehrabian, M., Schulthess, F. T., Neboháčová, M., Castellani, L. W., Zhou, Z., Hartiala, J., Oberholzer, J., Lusis, A. J., Maedler, K., & Allayee, H. (2008) · Diabetologia · doi:10.1007/s00125-008-1002-3 · Cited by 53
“genes controlling beta cell function also play an important role in adult-onset type 2 diabetes, suggesting that insulin secretion-related mechanisms may make more significant genetic contributions to common forms of type 2 diabetes than previously recognised [22–26].”
BackgroundDiabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis
Wilkin, T. J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00343.x · Cited by 49
Retinol-Binding Protein 4, Insulin Resistance, and Type 2 Diabetes
Polonsky, K. S. (2006) · New England Journal of Medicine · doi:10.1056/nejme068091 · Cited by 47
Ricaño-Ponce, I., Wijmenga, C., & Gutierrez‐Achury, J. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.04.004 · Cited by 54
The Architecture of Risk for Type 2 Diabetes: Understanding Asia in the Context of Global Findings
Abdullah, N., Attia, J. R., Oldmeadow, C. J., Scott, R. J., & Holliday, E. G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/593982 · Cited by 53
“This small study of early onset T2D reportedT2D-associated variants in three novel susceptibility genes: TCF7L2 and HHEX/IDE which are associated with 𝛽- cell function [101] and SLC30A8, encoding a zinc transporter highly expressed in pancreatic islets [102].”
BackgroundInfluentialSingh, K., Agrawal, N. K., Gupta, S., & Singh, K. (2013) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734613493289 · Cited by 55
Pharmacogenetics of Oral Antidiabetic Drugs
Becker, M. L., Pearson, E. R., & Tkáč, I. (2013) · International Journal of Endocrinology · doi:10.1155/2013/686315 · Cited by 52
“Among more than 50 gene variants associated with T2D, the variants in transcription factor 7-like 2 (TCF7L2) gene are the strongest predictors of increased risk of developing type 2 diabetes, a 40% increased risk per allele [29, 30].”
BackgroundFranzago, M., Fraticelli, F., Nicolucci, A., Celentano, C., Liberati, M., Stuppia, L., & Vitacolonna, E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4612623 · Cited by 50
“[12] reported that several SNPswithin intronic regions ofTCF7L2, including the rs7903146 (C>T), show significant associations with T2DM, and these findings have been replicated by numerous groups, demonstrating the rs7903146 (C>T) SNP as one of the most important T2DM susceptibility variants.”
BackgroundHuman Pluripotent Stem Cells to Model Islet Defects in Diabetes
Balboa, D., Iworima, D. G., & Kieffer, T. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.642152 · Cited by 45
Pathophysiological aspects of Wnt-signaling in endocrine disease
Schinner, S., Willenberg, H. S., Schott, M., & Scherbaum, W. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0831 · Cited by 50
p21-Activated protein kinases and their emerging roles in glucose homeostasis
Chiang, Y.-T. A., & Jin, T. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00506.2013 · Cited by 53
Association of TCF7L2 Gene Polymorphisms with Reduced Acute Insulin Response in Hispanic Americans
Palmer, N. D., Lehtinen, A. B., Langefeld, C. D., Campbell, J. K., Haffner, S. M., Norris, J. M., Bergman, R. N., Goodarzi, M. O., Rotter, J. I., & Bowden, D. W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1225 · Cited by 54
“032, respectively), which were strongly associated with T2D in the initial report (6).”
BackgroundResultInfluentialGoyal, S., Rani, J., Bhat, M. A., & Vanita, V. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.656 · Cited by 55
Assmann, T. S., Duarte, G. C. K., Rheinheimer, J., Cruz, L. A., Canani, L. H. S., & Crispim, D. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003510 · Cited by 51
Genetic variants affecting incretin sensitivity and incretin secretion
Müssig, K., Staiger, H., Machicao, F. E., Häring, H., & Fritsche, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1876-8 · Cited by 49
“In agreement with these in vitro data, genetic variants in TCF7L2 were identified to associate with an increased risk of type 2 diabetes in humans [53–55], with impaired insulin secretion as a potential link [29, 54, 56, 57].”
Result
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.